Biotech Stocks

H.C. Wainwright Maintains Buy on Kala Pharmaceuticals (KALA) Ahead of Upcoming PDUFA Date

H.C. Wainwright analyst Ram Selvaraju is out this morning with another bullish note on shares of Kala …

Key FDA Decisions Could Power These 3 Biopharma Stocks

Today, we list 3 biopharma companies that have FDA events approaching along with positive analyst …

TherapeuticsMD (TXMD): The Next 12-18 Months Could be a Period of Positive Stock Performance, Says Cantor

TherapeuticsMD (NASDAQ:TXMD) announced Friday that the FDA has approved its vaginal contraceptive system known as …

Will Senseonics (SENS) Stock Surge to $5? This Analyst Says Yes

Canaccord analyst Kyle Rose is out with a research note on shares of Senseonics (NYSE:SENS), after the medical …

Oppenheimer Bullish on TherapeuticsMD (TXMD) Following Expansion of Leading Portfolio

Oppenheimer analyst Jay Olson is out with a new research note on shares of TherapeuticsMD (NYSE:TXMD), following …

Cowen Slashes Price Target on Tesaro (TSRO) Stock on Back of Disappointing Guidance

Tesaro (NASDAQ:TSRO) investors got cold feet today, sending shares tumbling nearly 24%. The reason? The …

Kala Pharmaceuticals (KALA), Durect (DRRX), and Amarin (AMRN) Reiterated with a Buy at H.C. Wainwright

In a research note issued Wednesday, H.C. Wainwright analyst Ram Selvaraju reiterated coverage on shares …

Oppenheimer Sees 125% Upside for TherapeuticsMD (TXMD) Stock; Here’s Why

Oppenheimer analyst Jay Olson is out today with a bullish research note on shares of TherapeuticsMD …

Cantor Pounds the Table on TherapeuticsMD (TXMD) Stock

Cantor analyst William Tanner is out pounding the table on shares of TherapeuticsMD (NASDAQ:TXMD), reiterating an Overweight …